Research suggests that haritaki contains a diverse array of phytochemicals, including polyphenols, that may contribute to antioxidant activity and interactions with gut microbiota, both of which are relevant to how the body processes and neutralizes potentially harmful compounds. The available evidence in this area consists of a single 2024 metabolomics study using mass spectrometry to profile the chemical constituents of haritaki and its companion fruits in the traditional Triphala formulation, representing preliminary laboratory-based research rather than clinical trials in humans. While the study identified numerous bioactive compounds with predicted interactions at the molecular level, it did not directly test detoxification outcomes in living subjects, meaning the connection between haritaki's phytochemical profile and meaningful detoxification effects in humans remains to be established through clinical research. Overall, the current evidence base is narrow and largely foundational, and readers should be aware that mechanistic or metabolomics findings do not by themselves confirm health outcomes.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| A comprehensive metabolome profiling of Terminalia chebula, Terminalia beller... | Other | 2024 | Supports | 100 |